Medical - Pharmaceuticals
Compare Stocks
2 / 10Stock Comparison
LFMD vs AMZN
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Retail
LFMD vs AMZN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Pharmaceuticals | Specialty Retail |
| Market Cap | $215M | $2.92T |
| Revenue (TTM) | $219M | $742.78B |
| Net Income (TTM) | $-17M | $90.80B |
| Gross Margin | 86.7% | 50.6% |
| Operating Margin | -5.9% | 11.5% |
| Forward P/E | — | 34.8x |
| Total Debt | $6M | $152.99B |
| Cash & Equiv. | $37M | $86.81B |
LFMD vs AMZN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| LifeMD, Inc. (LFMD) | 100 | 309.7 | +209.7% |
| Amazon.com, Inc. (AMZN) | 100 | 222.1 | +122.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LFMD vs AMZN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LFMD is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth -8.7%, EPS growth 56.6%, 3Y rev CAGR 17.7%
- Lower volatility, beta 2.12, Low D/E 27.3%, current ratio 1.25x
- Better valuation composite
AMZN carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 1.51
- 7.0% 10Y total return vs LFMD's 220.7%
- Beta 1.51, current ratio 1.05x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.4% revenue growth vs LFMD's -8.7% | |
| Value | Better valuation composite | |
| Quality / Margins | 12.2% margin vs LFMD's -7.8% | |
| Stability / Safety | Beta 1.51 vs LFMD's 2.12 | |
| Dividends | 1.5% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +43.7% vs LFMD's -43.9% | |
| Efficiency (ROA) | 11.5% ROA vs LFMD's -24.3% |
LFMD vs AMZN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
LFMD vs AMZN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AMZN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 3385.1x LFMD's $219M. AMZN is the more profitable business, keeping 12.2% of every revenue dollar as net income compared to LFMD's -7.8%. On growth, AMZN holds the edge at +16.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $219M | $742.8B |
| EBITDAEarnings before interest/tax | -$5M | $155.9B |
| Net IncomeAfter-tax profit | -$17M | $90.8B |
| Free Cash FlowCash after capex | $15M | -$2.5B |
| Gross MarginGross profit ÷ Revenue | +86.7% | +50.6% |
| Operating MarginEBIT ÷ Revenue | -5.9% | +11.5% |
| Net MarginNet income ÷ Revenue | -7.8% | +12.2% |
| FCF MarginFCF ÷ Revenue | +6.8% | -0.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -23.6% | +16.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -16.0% | +74.8% |
Valuation Metrics
LFMD leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $215M | $2.92T |
| Enterprise ValueMkt cap + debt − cash | $185M | $2.98T |
| Trailing P/EPrice ÷ TTM EPS | -19.52x | 37.82x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 34.77x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.35x |
| EV / EBITDAEnterprise value multiple | — | 20.47x |
| Price / SalesMarket cap ÷ Revenue | 1.11x | 4.07x |
| Price / BookPrice ÷ Book value/share | 8.75x | 7.14x |
| Price / FCFMarket cap ÷ FCF | 33.61x | 378.98x |
Profitability & Efficiency
AMZN leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
AMZN delivers a 23.3% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $-162 for LFMD. LFMD carries lower financial leverage with a 0.27x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMZN's 0.37x. On the Piotroski fundamental quality scale (0–9), AMZN scores 6/9 vs LFMD's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -162.4% | +23.3% |
| ROA (TTM)Return on assets | -24.3% | +11.5% |
| ROICReturn on invested capital | — | +14.7% |
| ROCEReturn on capital employed | -37.4% | +15.3% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.27x | 0.37x |
| Net DebtTotal debt minus cash | -$30M | $66.2B |
| Cash & Equiv.Liquid assets | $37M | $86.8B |
| Total DebtShort + long-term debt | $6M | $153.0B |
| Interest CoverageEBIT ÷ Interest expense | -6.48x | 39.96x |
Total Returns (Dividends Reinvested)
Evenly matched — LFMD and AMZN each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMZN five years ago would be worth $16,476 today (with dividends reinvested), compared to $5,423 for LFMD. Over the past 12 months, AMZN leads with a +43.7% total return vs LFMD's -43.9%. The 3-year compound annual growth rate (CAGR) favors LFMD at 40.8% vs AMZN's 36.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +28.7% | +19.7% |
| 1-Year ReturnPast 12 months | -43.9% | +43.7% |
| 3-Year ReturnCumulative with dividends | +178.9% | +156.2% |
| 5-Year ReturnCumulative with dividends | -45.8% | +64.8% |
| 10-Year ReturnCumulative with dividends | +220.7% | +697.8% |
| CAGR (3Y)Annualised 3-year return | +40.8% | +36.8% |
Risk & Volatility
AMZN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
AMZN is the less volatile stock with a 1.51 beta — it tends to amplify market swings less than LFMD's 2.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 97.3% from its 52-week high vs LFMD's 28.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.12x | 1.51x |
| 52-Week HighHighest price in past year | $15.84 | $278.56 |
| 52-Week LowLowest price in past year | $2.56 | $185.01 |
| % of 52W HighCurrent price vs 52-week peak | +28.3% | +97.3% |
| RSI (14)Momentum oscillator 0–100 | 70.8 | 81.1 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 45.5M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates LFMD as "Buy" and AMZN as "Buy". Consensus price targets imply 89.3% upside for LFMD (target: $9) vs 13.1% for AMZN (target: $307). LFMD is the only dividend payer here at 1.53% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $8.50 | $306.77 |
| # AnalystsCovering analysts | 10 | 94 |
| Dividend YieldAnnual dividend ÷ price | +1.5% | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | $0.07 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
AMZN leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LFMD leads in 1 (Valuation Metrics). 1 tied.
LFMD vs AMZN: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is LFMD or AMZN a better buy right now?
For growth investors, Amazon.
com, Inc. (AMZN) is the stronger pick with 12. 4% revenue growth year-over-year, versus -8. 7% for LifeMD, Inc. (LFMD). Amazon. com, Inc. (AMZN) offers the better valuation at 37. 8x trailing P/E (34. 8x forward), making it the more compelling value choice. Analysts rate LifeMD, Inc. (LFMD) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — LFMD or AMZN?
Over the past 5 years, Amazon.
com, Inc. (AMZN) delivered a total return of +64. 8%, compared to -45. 8% for LifeMD, Inc. (LFMD). Over 10 years, the gap is even starker: AMZN returned +697. 8% versus LFMD's +220. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — LFMD or AMZN?
By beta (market sensitivity over 5 years), Amazon.
com, Inc. (AMZN) is the lower-risk stock at 1. 51β versus LifeMD, Inc. 's 2. 12β — meaning LFMD is approximately 40% more volatile than AMZN relative to the S&P 500. On balance sheet safety, LifeMD, Inc. (LFMD) carries a lower debt/equity ratio of 27% versus 37% for Amazon. com, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — LFMD or AMZN?
By revenue growth (latest reported year), Amazon.
com, Inc. (AMZN) is pulling ahead at 12. 4% versus -8. 7% for LifeMD, Inc. (LFMD). On earnings-per-share growth, the picture is similar: LifeMD, Inc. grew EPS 56. 6% year-over-year, compared to 29. 7% for Amazon. com, Inc.. Over a 3-year CAGR, LFMD leads at 17. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — LFMD or AMZN?
Amazon.
com, Inc. (AMZN) is the more profitable company, earning 10. 8% net margin versus -3. 7% for LifeMD, Inc. — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMZN leads at 11. 2% versus -4. 0% for LFMD. At the gross margin level — before operating expenses — LFMD leads at 79. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is LFMD or AMZN more undervalued right now?
Analyst consensus price targets imply the most upside for LFMD: 89.
3% to $8. 50.
07Which pays a better dividend — LFMD or AMZN?
In this comparison, LFMD (1.
5% yield) pays a dividend. AMZN does not pay a meaningful dividend and should not be held primarily for income.
08Is LFMD or AMZN better for a retirement portfolio?
For long-horizon retirement investors, Amazon.
com, Inc. (AMZN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+697. 8% 10Y return). LifeMD, Inc. (LFMD) carries a higher beta of 2. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AMZN: +697. 8%, LFMD: +220. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between LFMD and AMZN?
These companies operate in different sectors (LFMD (Healthcare) and AMZN (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
LFMD pays a dividend while AMZN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.